Work

Safety of SGLT2 inhibitors for patients with type 2 diabetes: where are we now?

Year: 2026

Type: article

Source: Expert Opinion on Drug Safety

DOI: 10.1080/14740338.2026.2666186

Author: André J. Scheen

Institutions: University of Liège, Centre Hospitalier Universitaire de Liège

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7155632391

FWCI:

Cites: 160

Cited by:

Related to: